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Abstract 
Swine Influenza Virus (H1N1) is a known causative agent of swine flu. Transmission of Swine Influenza Virus form pig to human is not a 
common event and may not always cause human influenza. The 2009 outbreak by subtype H1N1 in humans is due to transfer of Swine Influenza 
Virus from pig to human. Thus to analyze the origin of this novel virus we compared two surface proteins (HA and NA) with influenza viruses of 
swine, avian and humans isolates recovered from 1918 to 2008 outbreaks. Phylogenetic analyses of hemagglutinin gene from 2009 pandemic 
found to be clustered with swine influenza virus (H1N2) circulated in U.S.A during the 1999-2004 outbreaks. Whereas, neuraminidase gene was 
clustered with H1N1 strains isolated from Europe and Asia during 1992-2007 outbreaks. This study concludes that the new H1N1 strain appeared 
in 2009 outbreak with high pathogenicity to human was originated as result of re-assortment (exchange of gene). Moreover, our data also suggest 
that the virus will remain sensitive to the pre-existing therapeutic strategies. 
 
Keywords: H1N1; pandemic; sequence; analysis; mutations. 
 
Background 
A new H1N1 re-assortant "swine" influenza virus was recently
 
detected in individuals from the United States who
  presented 
respiratory symptoms, and the same virus was subsequently
 confirmed 
in patients from several countries around the world [1]. The World 
Health Organization (WHO) reported 94,512 cases of influenza A 
(H1N1) infection with a pandemic potential, including 429 deaths in 
July 06, 2009 [2]. The circumstances surrounding the emergence of 
this pathogen,
 and the factors that facilitated the initial cross-species 
transmission,
 are still not fully understood. It became apparent in the
 
early days of the outbreak that the virus can be directly transmitted
 
between humans. Among the various efforts made to evaluate, 
diagnose and implement measures against the spread of virus, is the 
timely release of the genomic sequences from different viral isolates.  
 
The notorious
  1918 influenza pandemic—deservedly known as the 
"mother
  of all pandemics"—infected more than one quarter of the
 
world's population and claimed an estimated 20 to 50 million
 human 
lives [3]. Two features of the influenza virus, compounded by current 
globalization
  trends, explain its ability to become a particularly 
worrisome
 zoonotic threat. One feature is the high error rate during 
genomic
 replication, which is typical of RNA viruses. The other is the
 
segmented influenza virus genome, which facilitates re-assortment
 
between different viral strains that infect the same cell.
 At a time when 
air travel makes it possible to reach the most
 remote corners of the 
planet in a matter of hours, any emerging
 or re-emerging infectious 
disease stops being a local issue
 and instead becomes a global medical 
and public health priority.
 Details of how the current influenza virus 
emerged, although
  still scarce, will enhance our knowledge about 
factors that
 enable viruses to cross the species barrier and cause disease
 
in humans [4]. Hence, keeping above things in our mind our lab has 
started analyses of this new (2009) human H1N1 virus and compared 
it with others H1N1 and H1N2 viruses from human, swine and avian 
during the outbreak occurred in 1918-2008. 
 
Methodology 
Nucleotide and protein sequences of haemagglutinin (HA) and 
neuraminidase (NA) were downloaded form NCBI database 
(ftp://ftp.ncbi.nih.gov/genomes/INFLUENZA). Blast server at NCBI 
was used to identify the sequences identity (Nucleotide and Protein). 
Alignments of the selected sequences of HA and NA genes were 
performed by ClustalW program with default parameters [5].  
Phylogenetic tree was built by Neighbour-joining method with 
Kimura-2 parameter, performed in Phylip3.65 package 
(http://evolution.genetics.washington.edu/phylip.html). Phylogenies 
were determined by bootstrap analyses of 1000 replicates using 
seqboot program available in Phylip3.65 package. Phylogenetic tree 
was drawn by TreeView1.6 program 
(http://taxonomy.zoology.gla.ac.uk/rod/treeview). Glycosylation sites 
were identified by Scanprosite (http://expasy.org/tools/scanprosite) at 
Expasy server.  
 
Discussion 
Pigs have been known as “mixing vessel” [6] and thus play a vital role 
in interspecies transmission of influenza viruses. A novel 2009 human 
H1N1 virus, circulating in USA, Europe and Asia is known to be a re-
assorted virus. Thus to trace out the origin of this novel human H1N1 
virus, we performed the phylogenetic analyses of two surface proteins 
(HA and NA). 
 
The haemagglutinin (HA) sequences of three strains form 2009 
outbreak (two from U.S.A and one from Asia) clustered with the swine 
influenza sequences from H1N2 subtype recovered from 1999-2004 
outbreaks in U.S.A (Figure1a). The HA gene sequences of all the 
three isolates shared highest homology over 95% and 93% at 
nucleotide and protein level was found with H1N2 strain from Indiana 
and H1N1 strain from Kansas, respectively (Table 1 in 
supplementary material).  In contrast, the segment coding for 
neuraminidase gene (NA) of new human virus clustered with the 
swine influenza viruses from Asia and Europe from 1992-2007 
outbreaks (Figure1b). However the NA genes of three isolates from 
2009 outbreak showed highest homology over 94% and 92% to H1N1 
strain from England and H1N1 strain from Belgium, respectively 
(Table 1 in supplementary material). Whereas H1N1 strain from 
Zhejiang shared at least 91% homology both at nucleotide and protein 
level. Thus our result suggests that the neuraminidase gene segment 
lies with in the Eurasian swine genetic lineage, which also 
corroborates with a recent report by Garten et al [7]. However all the 
humans isolates from H1N1 subtype recovered from 1995 to 2008 fail 
to clustered with these novel strains and able to make separate 
clustered . The HA and NA, genes from 2009 outbreak showed 
homology to 77% to 80% strains clustered in this group. Comparing 
the HA and NA genes from virus with 1918 outbreak we found that 
this novel virus shared at least 85% and 83% homology respectively.  
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Figure 1:  A Neighbour-Joining phylogenetic tree from nucleotide sequences of HA (a) and NA(b) of selected influenza A viruses. The tree was 
rooted to A/South Carolina/1/18(H1N1) for HA and A/Brevig Mission/1/18(H1N1) for NA. Robustness of individual nodes of the tree was 
determined by using boot strap analyses at 1000 replicates. Bioinformation   open access 
www.bioinformation.net    Hypothesis
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Figure 2: Amino acids comparison of the HA1 domain. Dots represent consensus similar amino acids. Conserved amino acids at receptor binding 
sites are shown as small rectangles. Red dots represent amino acids specific for NeuAcα2, 6 Gal SA. 
 
Alignment of HA1 amino acids sequences from 1918-2009 are shown 
in  Figure 2. Five conserved amino acids Tyr95, Tyr136, Trp153, 
His183, Tyr195 are highlighted at receptor-binding site of H1 which 
have been described by Skehel and Wiley [8]. With H1, SA binding 
was specific for the NeuAcα2,6 Gal linkage due to amino acids Asp-
190 and Asp-225, Although Mexican (2009) H1 isolate  had Gly225 
which is similar to isolates from Swine Influenza Virus during 1980 
and 1997 outbreaks in USA. Mutation at position 225 may effect the 
binding to NeuAcα2, 6 Gal SA but further needs to be validated by 
experimental approach. At least six potential  glycosylation sites have 
been identified at position 27-30, 28-31, 40-43, 104-107, 293- 296, 
304-307 at H1 in new human 2009 strains. All the glycosylation sites 
were related to Swine Influenza Virus H1 viruses recovered from 
1999-2001 outbreaks and that include subtype H1N2 and H1N1 in 
U.S.A (data not shown). These data suggest novel H1N1 virus was 
genetically related to viruses form swine H1N2 and H1N1 subtypes 
which give strong indication of re-assortment.  With the novel 2009 
virus, the amino acid sequence at receptor–binding site was similar to 
H1 of Swine influenza virus and human isolates from 1918-2008 
outbreaks, which further implicate the conserved   pattern of   receptor 
binding in present H1N1 virus.  
 
Previous reports suggested that mutations at amino acid H274Y and 
N294S made strain resistant to available drug oseltamivir [9]. Thus to 
investigate whether available drugs (oseltamivir, zanamivir) may be 
effective against the recent circulating virus, we performed the amino 
acids sequence alignment of NA gene with previous strains. The result 
revealed that no mutation was found in the conserved region of active 
site (data not shown), which is the potential target for the existing 
drugs.  Thus, conserved pattern at active site of NA suggests that the 
virus will remain sensitive to the pre-existing therapeutic strategies. 
Conclusion 
This study precisely intrigue to investigate the origin of novel virus 
(2009) subtype H1N1 (based on two surface proteins HA & NA) 
prevalent in humans. Our Insilco analyses revealed that this is a re-
assorted virus, where swine may constitute a crucial intermediate host 
for transmission. Furthermore, the study also predicts the presence of 
conserved domains in both the surface proteins, which could be of 
therapeutic relevance.  
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Supplementary material: 
Table 1: Nucleotide identies and protein identies of novel virus from 2009 pandemic 
2009 STRAINS(H1N1) 
A/Mexico/3955/09 A/New  York/18/09 A/Thailand/104/09 
 
PREVIOUS STRAINS 
  NU* PR
t  NU PR NU PR 
Neuraminidase (NA) 
A/Brevig  Mission/18  83 87 83 87 83 87 
A/Swine/England/195852/92  94 94 93 94 94 94 
A/Swine/Belgium/1/98  92 93 92 92 92 93 
A/Swine/Zhejiang/1/07  91 91 91 91 91 91 
A/Texas/27/08  79 80 79 80 79 80 
A/Hong  Kong/156/97(H5N1)  88 88 88 88 88 88 
Haemaggulutinin   (HA) 
A/South  Carolina/1918(H1N1)  82 85 82 86 82 86 
A/Wisconsin/1/2008(H1N1)  77 78 77 79 77 79 
A/Swine/kansas/00246/04(H1N2) 93 92 93 92 93 92 
A/Swine/Indiana/9k035/99(H1N2) 95 95 95 95 95 95 
A/Swine/Wisconsin/125/1997(H1N1  90 90 90 90 90 90 
A/Swine/Il0700324/2007(H1N1)  89  90  89  90  89  90 
*NU = Nucleotide; 
tPR = Protein 
 
 